Deadline: 24 October 2018
Deadline (2nd stage): 15 May 2019
Research Participant Portal - Funding Opportunities - Recently published Calls

CALL: H2020-JTI-IMI2-2018-15-TWO-STAGE
Call identifier: H2020-JTI-IMI2-2018-15-TWO-STAGE 
Publication date: 18 July 2018
Type of action: IMI2-RIA Research and Innovation action
Deadline model: two - stage

The submission session is now available for latter topics:

IMI2-2018-15-01: Integrated research platforms enabling patient-centric drug development

IMI2-2018-15-02: Blockchain Enabled Healthcare

IMI2-2018-15-03: Microenvironment imposed signatures in tissue and liquid biopsies in immune- mediated diseases

IMI2-2018-15-04: Emerging translational safety technologies and tools for interrogating human immuno-biology

IMI2-2018-15-05: Development and validation of translational platforms in support of synaptopathy drug discovery

IMI2-2018-15-06: Digital endpoints in neurodegenerative and immune-mediated diseases

IMI2-2018-15-07: AMR Accelerator programme Pillar A: Capability Building Network to accelerate and validate scientific discoveries

IMI2-2018-15-08: AMR Accelerator programme Pillar B: Tuberculosis drug development network to accelerate and validate scientific discoveries and advance the R&D pipeline of new and innovative agents to address the global tuberculosis epidemic

Source: EUc Ispiši stranicu